Jean Yves Pierga
AuthID: R-00J-CVH
1
TÃTULO: 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age Full Text
AUTORES: Piccart, M; 't Veer, LJV; Poncet, C; Cardozo, JMNL; Delaloge, S; Pierga, JY; Vuylsteke, P; Brain, E; Vrijaldenhoven, S; Neijenhuis, PA; Causeret, S; Smilde, TJ; Viale, G; Glas, AM; Delorenzi, M; Sotiriou, C; Rubio, IT; Kummel, S; Zoppoli, G; Thompson, AM; ...Mais
PUBLICAÇÃO: 2021, FONTE: LANCET ONCOLOGY, VOLUME: 22, NÚMERO: 4
AUTORES: Piccart, M; 't Veer, LJV; Poncet, C; Cardozo, JMNL; Delaloge, S; Pierga, JY; Vuylsteke, P; Brain, E; Vrijaldenhoven, S; Neijenhuis, PA; Causeret, S; Smilde, TJ; Viale, G; Glas, AM; Delorenzi, M; Sotiriou, C; Rubio, IT; Kummel, S; Zoppoli, G; Thompson, AM; ...Mais
PUBLICAÇÃO: 2021, FONTE: LANCET ONCOLOGY, VOLUME: 22, NÚMERO: 4
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial
AUTORES: Suzette Delaloge; Martine Piccart; Emiel Rutgers; Saskia Litiere; Laura J van't Veer; Franchette van den Berkmortel; Etienne Brain; Aleksandra Dudek Peric; Miguel Gil Gil; Patricia Gomez; Florentine S Hilbers; Zaman Khalil; Susan Knox; Sherko Kuemmel; Georg Kunz; Anne Lesur; Jean Yves Pierga; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; ...Mais
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 11
AUTORES: Suzette Delaloge; Martine Piccart; Emiel Rutgers; Saskia Litiere; Laura J van't Veer; Franchette van den Berkmortel; Etienne Brain; Aleksandra Dudek Peric; Miguel Gil Gil; Patricia Gomez; Florentine S Hilbers; Zaman Khalil; Susan Knox; Sherko Kuemmel; Georg Kunz; Anne Lesur; Jean Yves Pierga; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; ...Mais
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 11
INDEXADO EM: Scopus WOS
Scopus WOS3
TÃTULO: MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
AUTORES: Fatima Cardoso; Laura van't Veer; Coralie Poncet; Josephine Lopes Cardozo; Suzette Delaloge; Jean Yves Pierga; Peter Vuylsteke; Etienne Brain; Giuseppe Viale; Sherko Kuemmel; Isabel T Rubio; Gabriele Zoppoli; Alastair Mark Thompson; Erika Matos; Khalil Zaman; Florentine Hilbers; Aleksandra Dudek Peric; Bart Meulemans; Martine J Piccart Gebhart; Emiel J Rutgers;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15
AUTORES: Fatima Cardoso; Laura van't Veer; Coralie Poncet; Josephine Lopes Cardozo; Suzette Delaloge; Jean Yves Pierga; Peter Vuylsteke; Etienne Brain; Giuseppe Viale; Sherko Kuemmel; Isabel T Rubio; Gabriele Zoppoli; Alastair Mark Thompson; Erika Matos; Khalil Zaman; Florentine Hilbers; Aleksandra Dudek Peric; Bart Meulemans; Martine J Piccart Gebhart; Emiel J Rutgers;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15
INDEXADO EM: WOS
WOS